Investigation of Walking Training With Different Slope Types in COPD Patients

Официальное название

The Effect of Aerobic Exercise Training in Different Slope Types on Exercise Capacity, Respiratory Functions, Muscle Strength, and Functional Status in COPD Patients

Обзор

Chronic obstructive pulmonary disease (COPD) is a disease that continues to generate a great deal of research and this research must continue, both because it is not completely curable and because of the large patient population. The importance and benefits of exercise training in COPD patients are clear. One of the most preferred types of exercise training is the so-called aerobic exercise training, which typically takes the form of walking. A typical walking training does not use a slope or may include an uphill slope. However, recently there have been publications about downhill walking and its benefits in COPD. Walking on a level, uphill, and downhill slope may have the potential to result in different gains by using different muscle groups more. Therefore, this study aimed to compare the effects of walking training on exercise capacity, respiratory functions, muscle strength, and functional status in COPD patients with three different slope types: level, uphill, and downhill.

Подробное описание

The convenience sampling method will be used as the sampling method in the research.

In this study, sample size was calculated by a priori power analysis using G\*Power 3.1.9.4 software. In the analysis for analysis of variance (ANOVA: repeated measures, between factors) with two factors and repeated measures; effect size f = 0.62 (based on data obtained from previous study, Borghi-Silva et al, 2009), significance level α = 0.05, statistical power (1 - β) = 0.80, number of groups 3, number of measures 2 and correlation coefficient between measures r = 0.5. According to the calculation, it was predicted that the study would reach sufficient statistical power with a total of 24 participants, 8 participants in each group.

There will be three groups in the study: downhill walking, uphill walking, and level walking. The downhill walking and uphill walking groups will be included as the study group and the level walking group will be included as the control group. Participants will be distributed equally to the three groups. Patients will be assigned to these groups by block randomization method using https://www.randomizer.org/ website.

All three groups will be administered a 6-minute walking test at baseline, and participants will be subjected to a common 8-week, twice-weekly treadmill walking training program in which the speed is determined and increased according to the average speed they walk in this test, and in addition to this, the duration is also increased. One session of the training program will consist of warming up, loading, and cooling down on the treadmill.

During the training, the slope of the treadmill will be adjusted to +10 degrees for uphill walking, -10 degrees for downhill walking, and 0 degrees for level walking and will be kept constant for 8 weeks. A special wooden wedge apparatus will be made under the normal treadmill to give -10 downhill slope.

Primary outcome measurements will be made at baseline and at the end of week 8.

Вмешательства

• Другое Downhill walking training
  For 8 weeks, downhill walking training will be done 2 times a week at a slope of -10 degrees.
• Другое Level walking training
  For 8 weeks, level walking training will be done 2 times a week at a slope of 0 degrees.
• Другое Uphill walking training
  For 8 weeks, uphill walking training will be done 2 times a week at a slope of +10 degrees.

Первичные конечные точки

• 6 Minutes Walking Distance (6MWD) [Срок оценки: Up to 8 weeks.]
• Spirometric measurements (Forced vital capacity) [Срок оценки: Up to 8 weeks.]
• Spirometric measurements (First second forced expiratory volume) [Срок оценки: Up to 8 weeks.]
• Spirometric measurements (FEV1/FVC ratio) [Срок оценки: Up to 8 weeks.]
• Spirometric measurements (Peak Expiratory Flow) [Срок оценки: Up to 8 weeks.]
• Spirometric measurements (Maximum Intermediate Expiratory Flow) [Срок оценки: Up to 8 weeks.]
• Muscle strength measurements (skeletal muscles) [Срок оценки: Up to 8 weeks.]
• Muscle strength measurements (respiratory muscles) [Срок оценки: Up to 8 weeks.]
• 30-second sit and stand test [Срок оценки: Up to 8 weeks.]
• Functional performance inventory [Срок оценки: Up to 8 weeks.]

Вторичные конечные точки (3)

• Dyspnea [Срок оценки: Up to 8 weeks.]
• Fatigue [Срок оценки: Up to 8 weeks.]
• Level of exertion [Срок оценки: Up to 8 weeks.]

Критерии участия

Критерии включения

• Being diagnosed with COPD (A, B, E groups according to GOLD assessment)
• Ambulate on your own
• Not having any contraindications for exercise
• To be mentally appropriate (score 24 points and above in the mini mental test)

Критерии исключения

• Being in GOLD 4 stage in spirometric evaluation
• Presence of hypoxemia
• Participation in another pulmonary rehabilitation program within the last 6 months
• Having an exacerbation in the last 1 month
• Being diagnosed with additional respiratory disease (asthma, bronchiectasis, etc.)
• Having had pulmonary surgery
• Having an orthopedic, neurological or cardiac disease that affects exercise
• Having uncontrolled hypertension or diabetes
• Presence of malignancy

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Открытое

Основная цель

Поддерживающая терапия

Центры проведения

Turkey (Türkiye) · 1 центр

• Bezmialem Vakif University, Department of Physiotherapy and Rehabilitation — Istanbul

Публикации

• Borghi-Silva A, Arena R, Castello V, Simoes RP, Martins LE, Catai AM, Costa D. Aerobic exercise training improves autonomic nervous control in patients with COPD. Respir Med. 2009 Oct;103(10):1503-10. doi: 10.1016/j.rmed.2009.04.015. Epub 2009 May 22. PMID 19464865
• Franz JR, Kram R. The effects of grade and speed on leg muscle activations during walking. Gait Posture. 2012 Jan;35(1):143-7. doi: 10.1016/j.gaitpost.2011.08.025. Epub 2011 Oct 2. PMID 21962846
• Alexander N, Strutzenberger G, Ameshofer LM, Schwameder H. Lower limb joint work and joint work contribution during downhill and uphill walking at different inclinations. J Biomech. 2017 Aug 16;61:75-80. doi: 10.1016/j.jbiomech.2017.07.001. Epub 2017 Jul 11. PMID 28734544
• Moezy A, Erfani A, Mazaherinezhad A, Mousavi SAJ. Downhill walking influence on physical condition and quality of life in patients with COPD: A randomized controlled trial. Med J Islam Repub Iran. 2018 Jun 14;32:49. doi: 10.14196/mjiri.32.49. eCollection 2018. PMID 30159300
• Camillo CA, Burtin C, Hornikx M, Demeyer H, De Bent K, van Remoortel H, Osadnik CR, Janssens W, Troosters T. Physiological responses during downhill walking: A new exercise modality for subjects with chronic obstructive pulmonary disease? Chron Respir Dis. 2015 May;12(2):155-64. doi: 10.1177/1479972315575717. Epub 2015 Mar 10. PMID 25758676
• Erfani A, Moezy A, Mazaherinezhad A, Mousavi SA. Does Downhill Walking on Treadmill Improve Physical Status and Quality of Life of A Patient With COPD? Asian J Sports Med. 2015 Dec;6(4):e25821. doi: 10.5812/asjsm.25821. Epub 2015 Dec 1. PMID 26715973
• Camillo CA, Osadnik CR, Burtin C, Everaerts S, Hornikx M, Demeyer H, Loeckx M, Rodrigues FM, Maes K, Gayan-Ramirez G, Janssens W, Troosters T. Effects of downhill walking in pulmonary rehabilitation for patients with COPD: a randomised controlled trial. Eur Respir J. 2020 Sep 17;56(3):2000639. doi: 10.1183/13993003.00639-2020. Print 2020 Sep. PMID 32444407
• Leidy NK. Psychometric properties of the functional performance inventory in patients with chronic obstructive pulmonary disease. Nurs Res. 1999 Jan-Feb;48(1):20-8. doi: 10.1097/00006199-199901000-00004. PMID 10029398

Идентификаторы

NCT: NCT06283004 · 2024-1/30

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗